The U.S. technology sector continues to grow rapidly, driving the nation’s innovation and overall economic growth. However, technology companies are concentrated in only a few very high-cost hubs, such as Silicon Valley, Boston, and Seattle—creating a “winner-take-most” regional reality.
Join ITIF for the release of a new report on using tax incentives to drive clean energy innovation and a discussion of key issues and Congressional activity with an expert panel.
Global competition is intensifying and Europe is taking measures to deepen its innovation and risk-taking capability to compete in global markets increasingly defined by new technologies.
Join ITIF's Center for Data Innovation for a high-level forum to connect stakeholders working to promote AI in Europe, showcase advances in AI, and promote AI policies supporting its development to EU policymakers and thought leaders.
Join ITIF for a conversation about the potential applications of facial recognition technology, industry best practices in the use of the technology, and policies that spur innovation and deployment while preserving privacy and security.
ITIF's Center for Data Innovation in Brussels hosted and event that discussed how the EU should modernize the eCommerce Directive so as to protect consumers without unnecessarily hindering innovation.
ITIF and the Bipartisan Policy Center held an expert panel exploring the history solar energy innovations, China's role and influence on solar's diffusion as a leading manufacturer of solar panels, and the future of clean energy innovation.
ITIF hosted an expert panel discussion marking the release of a new report discussing the future of the federal government’s Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs and the role small businesses can play in driving innovation.
ITIF's Center for Data Innovation released a new report exploring opportunities to accelerate data-driven innovation in drug development and hosted a panel discussion about the ways data can make drug development faster, more efficient, and lead to new cures.